Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 10-Q: Q2 2024 Earnings Report
Clearside Biomedical | 8-K: Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Officer Chong Ngai Hang Victor
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Officer Chong Ngai Hang Victor
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director SHAFFER CHRISTY L
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Thorp Clay
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Humphries William D.
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director EDWARDS JEFFREY L
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Croarkin Richard
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Hutson Nancy J
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director YERXA BENJAMIN R
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Gibney Anthony S
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 4: Statement of changes in beneficial ownership of securities-Director YERXA BENJAMIN R
Clearside Biomedical | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Clearside Biomedical | 10-Q: Q1 2024 Earnings Report
Clearside Biomedical | 8-K: Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
Clearside Biomedical | ARS: Annual Report to Security Holders
No Data
No Data